The Determinants of Delays and Their Impact on Clinical End Points in Acute ST-Segment Elevation Myocardial

Kardelen Ohtaroglu Tokdil1, Hasan Tokdil2, Eser Durmaz1

  • 1Division of Cardiology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, 34098 Istanbul, Turkey.

PubMed

Insights

Factors like BMI, diabetes, and hypertension significantly delay treatment for ST-elevation myocardial infarction (STEMI) patients. Early intervention improves prognosis, reducing cardiac events and mortality.

Area of Science:

  • Cardiology
  • Public Health

Background:

  • ST-elevation myocardial infarction (STEMI) is a critical condition requiring rapid treatment.
  • Delays in treatment negatively impact patient prognosis and outcomes.

Purpose of the Study:

  • To identify factors contributing to treatment delay in STEMI patients.
  • To investigate the impact of treatment delay on major adverse cardiac events.

Main Methods:

  • A study of 301 STEMI patients undergoing primary percutaneous coronary intervention (pPCI).
  • Analysis of patient demographics, clinical factors, and treatment times.
  • Assessment of major cardiac clinical events and follow-up data.

Main Results:

  • Obesity (BMI), diabetes, hypertension, smoking, and pain intensity variability were linked to longer delays.
  • Independent predictors of delay included BMI, diabetes, hypertension, smoking, pain intensity, and non-LAD infarct artery.
  • Early presentation correlated with lower NT-proBNP and improved ejection fraction.

Conclusions:

  • Prolonged ischemia in STEMI is influenced by patient and system factors.
  • Timely reperfusion is crucial for reducing mortality and clinical events in STEMI.
  • Enhancing patient education, emergency response, and hospital protocols can minimize delays and improve STEMI outcomes.